Ségolène Falquero

Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)

Cécile Cieuta‐Walti, Aida Cuenca‐Royo, Klaus Langohr et al. · Genetics in Medicine · 2022 · 34 citations · Full text

Medicine, Nutrition, Pediatrics +17

Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium

Frode Larsen, R. Asaad Baksh, Eimear McGlinchey et al. · Alzheimer s & Dementia · 2024 · 27 citations · Full text

Medicine, Neurology, Psychiatry +17

The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation1

Alain D. Dekker, Aurora M. Ulgiati, Henk Groen et al. · Journal of Alzheimer s Disease · 2021 · 25 citations · Full text

Medicine, Psychiatry, Psychology +17

Early detection and treatment of obstructive sleep apnoea in infants with Down syndrome: a prospective, non-randomised, controlled, interventional study

Brigitte Fauroux, Silvia Sacco, Vincent Couloigner et al. · The Lancet Regional Health - Europe · 2024 · 19 citations · Full text

Medicine, Neuroscience, Pediatrics +17

Efficacy and safety of methylphenidate on attention deficit hyperactivity disorder in children with Down syndrome

Mathilde Roche, Clotilde Mircher, Jeanne Toulas et al. · Journal of Intellectual Disability Research · 2021 · 14 citations

Medicine, Pediatrics, Pharmacotherapy +17